Clinical Observation of Shensong Yangxin Capsules in the Treatment of the Elderly with CHD-induced Premature Ventricular Contraction of Qi-yin Deficiency Pattern and Stagnation of Cardiac Collateral Pattern
Objective:To observe the influence of Shensong Yangxin capsules on clinical effects,the number of ventricular premature beats in dynamic ECG and TCM syndrome integrals in the elderly with coronary heart disease(CHD)-induced premature ventricular contraction of Qi-yin deficiency,stagnation of cardiac collateral pattern.Methods:All 60 patients were chosen,allocated to the control group and the observation group with 30 cases in each group according to random number table method.The control group orally took metoprolol tartrate,and the observation group accepted oral administration of Shensong Yangxin capsules based on the therapy the control group received.Both groups were treated for four weeks consecutively.To observe clinical effects before and after the treatment,the number of ventricular premature beats in 24h dynamic ECG and TCM syndrome integrals between both groups.Results:The effective rate of the observation group was[96.67%(29/30)],higher than[73.33%(22/30)]of the control group(P＜0.05).After the treatment,the number of ventricular premature beats reduced in the two groups,the decrease of the observation group was more clear than that of the control group(P＜0.05),Compared with before treatment,the integrals of TCM syndromes including palpitation,throbbing restlessness,fatigue,panting and sphoria with feverish sensation in chest,palms and soles were reduced in the two groups(P＜0.05),and after the treatment,the improvements of these indexes of the observation group were superior to these of the control group(P＜0.05).Conclusion:Shensong Yangxin capsules could effectively reduce the number of ventricular premature beats and improve clinical symptoms in the elderly patients suffering CHD-induced premature ventricular contraction.
NETL
NSTL
万方数据
维普
